Osmotic demyelination syndrome, overcorrection of severe hyponatremia: A case report

  • Lưu Thúy Quỳnh Bệnh viện Trung ương Quân đội 108
  • Phạm Văn Cường Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Thủy Bệnh viện Trung ương Quân đội 108
  • Vũ Thị Loan Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Thùy Linh Bệnh viện Trung ương Quân đội 108
  • Lê Bích Nhàn Bệnh viện Trung ương Quân đội 108
  • Nguyễn Văn Mạnh Bệnh viện Trung ương Quân đội 108
  • Phạm Hồng Nhung Bệnh viện Trung ương Quân đội 108
  • Lê Thu Hiền Bệnh viện Trung ương Quân đội 108
  • Ngô Thị Phượng Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Osmotic demyelination syndrome, hyponatremia

Abstract

The osmotic demyelination syndrome (ODS) has been recognized as a complication of the rapid correction of hyponatremia. The pathophysiology of ODS consists loss of myelin due to osmotic stress. It has a high mortality and usually need aggressive supportive management in the intensive care unit. We report a case of ODS due to overcorrection of severe hyponatremia with pathognomonic clinical and radiologic signs making a nearly complete neurological recovery. Conclusion: Osmoic demyelination syndrome is a complication of overcorrection of severe hyponatremia. Treatment options for ODS are limited to case report however a combination of immunoglobulin, steroid and plasma exchange was administered not only during the early stage of illness but also helped to improve the neurological outcome.

Article Details

References

1. Wright DG, Laureno R, Victor M (1979) Pontine and extrapontine myelinolysis. Brain J Neurol 102(2): 361-385.
2. Sterns RH (1987) Severe symptomatic hyponatremia: Treatment and outcome. A study of 64 cases. Ann Intern Med 107(5): 656-664.
3. Sterns RH, Thomas DJ, Herndon RM (1989) Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int 35(1): 69-75.
4. George JC, Zafar W, Bucaloiu ID, Chang AR (2018) Risk factors and outcomes of rapid correction of severe hyponatremia. Clin J Am Soc Nephrol CJASN 13(7): 984-992.
5. Martin RJ (2004) Central pontine and extrapontine myelinolysis: The osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 75(3): 22-28.
6. Ahmed A, Asimi R, Sharma A, Nazir S (2007) Diagnosis: Osmotic myelinolysis (central pontine myelinolysis and extrapontine myelinolysis). Ann Saudi Med 27(4): 308-311.
7. Menger H, Jörg J (1999) Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 246(8): 700-705.
8. Louis G, Megarbane B, Lavoué S, Lassalle V, Argaud L, Poussel JF et al (2012) Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis. Crit Care Med 40(3): 970-972.
9. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170(3): 1-47.
10. Bansal LR (2018) Therapeutic effect of steroids in osmotic demyelination of infancy. Child Neurol Open 15(5): 2329048X18770576.
11. Singh TD, Fugate JE, Rabinstein AA (2014) Central pontine and extrapontine myelinolysis: A systematic review. Eur J Neurol 21(12): 1443-1450.
12. Tandukar S, Sterns RH, Rondon-Berrios H (2021) Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤ 10mEq/L per Day. Kidney 2(9): 1415-1423.